The Food & Drug Administration (FDA) recently approved the use of an HIV treatment medication for HIV-negative people at high risk of getting HIV through sexual exposure. Known as “pre-exposure prophylaxis”—or PrEP—this medication is a once-a-day pill to be used in combination with condoms and other safer sex behavioral strategies to reduce risk. Protecting Yourself from HIV through PrEP informs consumers about PrEP and how it works, as well as other ways they can work with their health care providers to protect themselves against HIV.
Search Results for: behavioral health
Supporting LGBTQ Youth: Providing Affirmative and Inclusive Care across the Spectrum of Gender and Sexual Identity
Lesbian, gay, bisexual, transgender, and queer (LGBTQ) children and adolescents must navigate the typical developmental challenges of growing up, in addition to managing the stigma and isolation that may face as a result of their emerging sexual and gender minority identities. These challenges often result in poorer health outcomes for LGBTQ children and adolescents such as higher risk for certain behavioral and emotional issues, poor sexual health outcomes, homelessness, as well as bullying and other forms of victimization. This webinar discusses the unique challenges and health disparities experienced by LGBTQ children and adolescents, and describes strategies to address these issues in a clinical setting. Though culturally appropriate and strength-based communication with LGBT children and adolescents, providers can be key facilitators in improving the health and well-being of sexual and gender minority youth.
- Filed under
- LGBTQIA+ Children and Youth
A New Era of Highly Effective HIV Prevention: The Role of Primary Care (Two-Part Webinar Series)
Part 1: Implementing HIV Prevention in Patient Centered Medical Homes and Primary Care Sponsor: National LGBT Health Education Center Speakers: Kevin Ard, MD, MPH and Harvey J. Makadon, MD First presented on October 30, 2012 Archived Primary care providers now have an expanding number of effective HIV prevention tools at their fingertips, including behavioral and biomedical interventions. This webinar gives step by step guidance on how clinicians can be most effective at preventing new HIV infections in their patients. Included is a discussion of evidence-based High Impact HIV Prevention Programs as recommended by the CDC as well as how to optimize implementation of HIV prevention programs in patient centered medical homes and other primary care programs. Part 2: Antiretrovirals for HIV Prevention: PEP and PrEP in Clinical Practice Sponsor: National LGBT Health Education Center Speaker: Ken Mayer, MD First presented on November 6, 2012 Archived Ken Mayer, MD, one of the world's foremost experts in HIV/AIDS research and practice lead participants in a presentation and discussion of the latest HIV prevention innovations that can be used in primary care settings. These advances include Post-Exposure Prophylaxis (PEP) as well as the newly FDA-approved Pre-Exposure Prophylaxis (PrEP). PrEP is the daily use of antiretroviral medication to help prevent HIV in uninfected high-risk people, while PEP is the short-term use of antiretroviral medication after a high-risk exposure.
Recent Breakthroughs in HIV Prevention for Transgender People and Men who Have Sex with Men
Health care providers now have an expanding number of effective HIV prevention tools at their fingertips, including behavioral and biomedical interventions. This session provides step by step guidance on how clinicians can be most effective at preventing new HIV infections in high-risk MSM and transgender patients. Included is a discussion of evidence-based High Impact HIV Prevention Programs as recommended by the CDC, and how best to optimize implementation of HIV prevention programs in patient centered medical homes (PCMH) and other primary care settings.
Caring for LGBT Youth in Clinical Settings
Lesbian, gay, bisexual, transgender (LGBT) youth (12-24 years) must navigate the typical challenges of adolescence while also managing the social stigma associated with their emerging sexual and gender minority identities. As a result, many LGBT youth are at higher risk for certain behavioral and emotional issues, homelessness, as well as bullying and other forms of victimization. In this webinar, Dr. Rob Garofalo – a nationally-recognized expert on LGBT health and adolescent identity development -- discusses the unique health and developmental challenges of LGBT youth, and describes ways to address these issues in the clinical setting. Through sensitive, confidential communication with LGBT youth, clinicians can become a vital source of support for this vulnerable population.
- Filed under
- LGBTQIA+ Children and Youth
Caring for LGBTQ Youth in Clinical Settings
Lesbian, gay, bisexual, transgender, and queer (LGBTQ) youth (12-24 years) must navigate the typical challenges of adolescence while also managing the social stigma associated with their emerging sexual and gender minority identities. As a result, many LGBT youth are at higher risk for certain behavioral and emotional issues, homelessness, as well as bullying and other forms of victimization. This module discusses the unique health and developmental challenges of LGBT youth, and describes ways to address these issues in the clinical setting. Through sensitive, confidential communication with LGBT youth, clinicians can become a vital source of support for this vulnerable population.
Carlos E. Rodríguez-Díaz, PhD, MPHE, MCHES
Dr. Rodriguez-Diaz is a community health educator and a sociobehavioral scientist with experiences in health promotion, health policy, human rights, and health diplomacy. He has been working in the LGBT health field in Puerto Rico, United States of America, and the Caribbean for over 15 years and has collaborated in advocacy and research initiatives with governmental and non-governmental organizations.
Sari Reisner, ScD
Sari Reisner, ScD is Director of Transgender Research and Assistant Professor in the Department of Medicine at Harvard Medical School, based in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women's Hospital, and Assistant Professor in the Department of Epidemiology at Harvard T.H. Chan School of public Health. He is also an Affiliated Research Scientist and Director of the Transgender Health Research Team at The Fenway Institute at Fenway Health.
Kenneth Mayer, MD
Dr. Mayer is a Professor at Harvard Medical School and the Harvard School of Public Health, and Attending Physician at Beth Israel Deaconess Medical Center in Boston and Director of HIV Prevention Research there. He is the founder, Co-Chair and Medical Research Director of The Fenway Institute, the research, training and health policy division of Fenway Health, the largest ambulatory facility caring for HIV-infected patients in New England.